|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1976-3-20
|
|
pubmed:abstractText |
When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17-valerate cream in a double-blind study on 49 patients with atopic dermatitis or atopic winter feet, betamethasone cream was found to be the most potent. The study also showed that in approximately 60% of the patients the clinical response was equal. It is suggested that the urea-hydrocortisone combination may have its place in the long-term topical treatment of atopic dermatitis on account of its water-binding effect.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0011-9075
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
151
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
30-3
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1107090-Administration, Topical,
pubmed-meshheading:1107090-Anti-Inflammatory Agents,
pubmed-meshheading:1107090-Betamethasone,
pubmed-meshheading:1107090-Betamethasone 17-Valerate,
pubmed-meshheading:1107090-Burns, Chemical,
pubmed-meshheading:1107090-Clinical Trials as Topic,
pubmed-meshheading:1107090-Dermatitis, Atopic,
pubmed-meshheading:1107090-Drug Combinations,
pubmed-meshheading:1107090-Erythema,
pubmed-meshheading:1107090-Humans,
pubmed-meshheading:1107090-Hydrocortisone,
pubmed-meshheading:1107090-Time Factors,
pubmed-meshheading:1107090-Urea
|
|
pubmed:year |
1975
|
|
pubmed:articleTitle |
Topical treatment with urea-hydrocortisone in atopic dermatitis. A controlled study against betamethasone 17-valerate.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Controlled Clinical Trial
|
